ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,917,000 | -6.0% | 116,939 | -25.3% | 0.87% | +25.9% |
| Q3 2016 | $4,166,000 | +9.5% | 156,547 | -9.3% | 0.69% | +17.4% |
| Q2 2016 | $3,805,000 | -35.5% | 172,557 | -14.1% | 0.59% | -28.8% |
| Q1 2016 | $5,901,000 | -18.4% | 200,926 | -8.3% | 0.83% | -32.4% |
| Q4 2015 | $7,235,000 | -19.2% | 219,098 | -11.6% | 1.23% | -9.4% |
| Q3 2015 | $8,958,000 | – | 247,856 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |